Immunome Inc. IMNM
- IM-1021 — B-Cell Lymphoma Phase 1
- IM-1021 — Non-Small Cell Lung Cancer Phase 1
- IM-1021 — Triple-Negative Breast Cancer Phase 1
- IM-1021 — Ovarian Cancer Phase 1
ROR1 (1 companies · 4 programs)
Companies with an active program directed at ROR1.